IBDEI15X ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18870,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,18870,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,18871,0)
 ;;=D86.81^^64^841^44
 ;;^UTILITY(U,$J,358.3,18871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18871,1,3,0)
 ;;=3^Sarcoid Meningitis
 ;;^UTILITY(U,$J,358.3,18871,1,4,0)
 ;;=4^D86.81
 ;;^UTILITY(U,$J,358.3,18871,2)
 ;;=^5002446
 ;;^UTILITY(U,$J,358.3,18872,0)
 ;;=D86.85^^64^841^45
 ;;^UTILITY(U,$J,358.3,18872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18872,1,3,0)
 ;;=3^Sarcoid Myocarditis
 ;;^UTILITY(U,$J,358.3,18872,1,4,0)
 ;;=4^D86.85
 ;;^UTILITY(U,$J,358.3,18872,2)
 ;;=^5002450
 ;;^UTILITY(U,$J,358.3,18873,0)
 ;;=D86.87^^64^841^46
 ;;^UTILITY(U,$J,358.3,18873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18873,1,3,0)
 ;;=3^Sarcoid Myositis
 ;;^UTILITY(U,$J,358.3,18873,1,4,0)
 ;;=4^D86.87
 ;;^UTILITY(U,$J,358.3,18873,2)
 ;;=^5002452
 ;;^UTILITY(U,$J,358.3,18874,0)
 ;;=D86.84^^64^841^47
 ;;^UTILITY(U,$J,358.3,18874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18874,1,3,0)
 ;;=3^Sarcoid Pyelonephritis
 ;;^UTILITY(U,$J,358.3,18874,1,4,0)
 ;;=4^D86.84
 ;;^UTILITY(U,$J,358.3,18874,2)
 ;;=^5002449
 ;;^UTILITY(U,$J,358.3,18875,0)
 ;;=D86.0^^64^841^48
 ;;^UTILITY(U,$J,358.3,18875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18875,1,3,0)
 ;;=3^Sarcoidosis of Lung
 ;;^UTILITY(U,$J,358.3,18875,1,4,0)
 ;;=4^D86.0
 ;;^UTILITY(U,$J,358.3,18875,2)
 ;;=^5002442
 ;;^UTILITY(U,$J,358.3,18876,0)
 ;;=D86.2^^64^841^49
 ;;^UTILITY(U,$J,358.3,18876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18876,1,3,0)
 ;;=3^Sarcoidosis of Lung w/ Sarcoidosis of Lymph Nodes
 ;;^UTILITY(U,$J,358.3,18876,1,4,0)
 ;;=4^D86.2
 ;;^UTILITY(U,$J,358.3,18876,2)
 ;;=^5002444
 ;;^UTILITY(U,$J,358.3,18877,0)
 ;;=D86.1^^64^841^50
 ;;^UTILITY(U,$J,358.3,18877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18877,1,3,0)
 ;;=3^Sarcoidosis of Lymph Nodes
 ;;^UTILITY(U,$J,358.3,18877,1,4,0)
 ;;=4^D86.1
 ;;^UTILITY(U,$J,358.3,18877,2)
 ;;=^5002443
 ;;^UTILITY(U,$J,358.3,18878,0)
 ;;=D86.89^^64^841^51
 ;;^UTILITY(U,$J,358.3,18878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18878,1,3,0)
 ;;=3^Sarcoidosis of Oth Sites
 ;;^UTILITY(U,$J,358.3,18878,1,4,0)
 ;;=4^D86.89
 ;;^UTILITY(U,$J,358.3,18878,2)
 ;;=^5002453
 ;;^UTILITY(U,$J,358.3,18879,0)
 ;;=D86.3^^64^841^52
 ;;^UTILITY(U,$J,358.3,18879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18879,1,3,0)
 ;;=3^Sarcoidosis of Skin
 ;;^UTILITY(U,$J,358.3,18879,1,4,0)
 ;;=4^D86.3
 ;;^UTILITY(U,$J,358.3,18879,2)
 ;;=^5002445
 ;;^UTILITY(U,$J,358.3,18880,0)
 ;;=D86.9^^64^841^53
 ;;^UTILITY(U,$J,358.3,18880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18880,1,3,0)
 ;;=3^Sarcoidosis,Unspec
 ;;^UTILITY(U,$J,358.3,18880,1,4,0)
 ;;=4^D86.9
 ;;^UTILITY(U,$J,358.3,18880,2)
 ;;=^5002454
 ;;^UTILITY(U,$J,358.3,18881,0)
 ;;=M35.01^^64^841^54
 ;;^UTILITY(U,$J,358.3,18881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18881,1,3,0)
 ;;=3^Sicca Syndrome w/ Keratoconjunctivitis
 ;;^UTILITY(U,$J,358.3,18881,1,4,0)
 ;;=4^M35.01
 ;;^UTILITY(U,$J,358.3,18881,2)
 ;;=^5011787
 ;;^UTILITY(U,$J,358.3,18882,0)
 ;;=M35.02^^64^841^55
 ;;^UTILITY(U,$J,358.3,18882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18882,1,3,0)
 ;;=3^Sicca Syndrome w/ Lung Involvement
 ;;^UTILITY(U,$J,358.3,18882,1,4,0)
 ;;=4^M35.02
 ;;^UTILITY(U,$J,358.3,18882,2)
 ;;=^5011788
 ;;^UTILITY(U,$J,358.3,18883,0)
 ;;=M35.03^^64^841^56
 ;;^UTILITY(U,$J,358.3,18883,1,0)
 ;;=^358.31IA^4^2
